Osaic Holdings
NVAX icon

Osaic Holdings’s Novavax NVAX Stock Holding History

Osaic Holdings’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2
Closed -$5K – 7553
2022
Q4 		$5K Hold
2
– – ﹤0.01% 6294
2022
Q3 		$4K Hold
2
– – ﹤0.01% 6500
2022
Q2 		$2K Hold
2
– – ﹤0.01% 6909
2022
Q1 		$1K Buy
+2
New +$178 ﹤0.01% 7084

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $605M AUM 43.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Osaic Holdings's NVAX Position: Q2 2026 in Review

Osaic Holdings increased its Novavax (NVAX) stake by 3.2% in Q2 2026, buying an estimated $13.6K and bringing the position to 49,460 shares worth $466K. The position accounts for ﹤0.01% of the portfolio, ranked #3731.

Osaic Holdings first reported a position in NVAX in Q1 2020 and has held it in 26 quarters since. The position peaked at $10.7M in Q4 2021. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Osaic Holdings held 49,460 shares of Novavax worth $466K as of Q2 2026.
  • Osaic Holdings bought 1,517 Novavax shares in Q2 2026, an estimated $13.6K.
  • Novavax made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3731 holding.
  • Osaic Holdings first reported a position in Novavax in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Novavax position peaked at $10.7M in Q4 2021.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.